newsfilter
← Latest News
GlobeNewswire·

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

  • Solésence, Inc. (NASDAQ: SLSN) announced the commercial availability of two proprietary platform technologies: WHSPR™ and Chromalüm™, available globally through finished goods.
  • WHSPR™ is a patented delivery system for allantoin that enables high-concentration usage in anhydrous formats like serums, balms, & face oils for OTC-sensitive skin claims.
  • Clinical studies on WHSPR™ showed up to 63% reduction in redness, 36% improvement in barrier recovery, 23% increase in barrier strength, & up to 112% immediate hydration improvement.
  • Chromalüm™ is a precision color technology designed to integrate broad-spectrum SPF & high-energy visible (HEV) light protection into color cosmetics without compromising aesthetics.
  • The Chromalüm™ system works with Solésence's Kleair™ technology to support high-SPF, water-resistant, & high-sheer formulations across skincare, suncare, & color cosmetics.
  • Both technologies allow brand partners to access clinically validated performance & regulatory-compliant marketing positions through Solésence's vertically integrated finished goods model.
  • Solésence President Kevin Cureton stated the launch opens product categories previously out of reach & expands opportunities into adjacent sectors like hair & scalp care.
  • The company plans to utilize its single manufacturing relationship to deliver breakthrough innovation while handling formulation, manufacturing, & quality assurance end-to-end.